Class II · Moderate risk
Rasagiline Tablets 0.5mg
Failed dissolution specifications - results obtained were below spec average.
Is Rasagiline recalled?
Not under an active recall.
Rasagiline was recalled 3 times in the past — all now closed. Most recent: Aug 2, 2023.
Most common reason: Dissolution failure (1 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Rasagiline. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Rasagiline recalls on record
none so far in 2026; 3 on record, newest first
Class II · Moderate risk
Rasagiline Mesylate Tablets 1 mg
Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.
Class II · Moderate risk
Rasagiline Mesylate
Labeling:Label Mixup; RASAGILINE MESYLATE, Tablet, 0.5 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W002690, EXP: 6/5/2014.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.